Fosun Pharma Proposed To Purchase List Pharmaceutical

Fosun Pharma proposed to use 747 million RMB to purchase 70.56 million stock from List Pharmaceutical. List Pharmaceutical was founded back in 2002, their main product is penehyclidine hydrochloride injection, a new type of anticholinergic drugs, mainly used in pre-anesthesia medication, organophosphorus pesticide poisoning rescue, shock, respiratory diseases and addiction treatment.

List Pharmaceutical has failed many times to get their IPO, and Fosun Pharma believes the acquisition of List Pharmaceutical would improve the company’s profits since they believe this acquisition would improve the company’s market share and production lines.